SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech informs about newspaper publication

27 Aug 2024 Evaluate
Vivo Bio Tech has enclosed copies of advertisement issued in newspapers today, i.e. on August 27, 2024, in ‘Financial Express’ in English Language and in ‘Nava Telangana’ in Telugu Language, with respect to the intimation of conducting 37th Annual General Meeting (AGM) of the Company through Video Conferencing / Other Audio Visuals Means (VC/OAVM) facility, without physical presence of members at the common venue and the manner of registering/ updating the email ids of the members of the Company with the Registrar and Share Transfer Agents (RTA) and other details as per the Ministry of Corporate Affairs & SEBI circulars.

The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech Share Price

29.30 0.38 (1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×